Responding to SARS-CoV-2 in South Africa: What Can We Learn from Drug-resistant Tuberculosis?

Overview

Journal Eur Respir J

Specialty Pulmonary Medicine

Date 2020 May 31

PMID 32471936

Citations 5

Authors

Norbert Ndjeka

Francesca Conradie

Graeme Meintjes

Anja Reuter

Jennifer Hughes

Xavier Padanilam

Nazir Ismail

Yulene Kock

Iqbal Master

Rodolfo Romero

Julian Te Riele

Martin Enwerem

Hannetjie Ferreira

Gary Maartens

Affiliations

Soon will be listed here.

Citing Articles

Drug-Resistant Tuberculosis and COVID-19: A Scoping Review on a New Threat to Antimicrobial Resistance.

Silva B, Almeida A, Sergio M, Gatto T, Carasek V, Yamamura M Rev Bras Enferm. 2023; 76Suppl 1(Suppl 1):e20220803.

PMID: 38055430 PMC: 10695069. DOI: 10.1590/0034-7167-2022-0803.

TB control in India in the COVID era.

Behera D Indian J Tuberc. 2021; 68(1):128-133.

PMID: 33641833 PMC: 7452904. DOI: 10.1016/j.ijtb.2020.08.019.

Diagnosed with TB in the era of COVID-19: patient perspectives in Zambia.

Mwamba C, Kerkhoff A, Kagujje M, Lungu P, Muyoyeta M, Sharma A Public Health Action. 2021; 10(4):141-146.

PMID: 33437679 PMC: 7790493. DOI: 10.5588/pha.20.0053.

Translating scientific discoveries during pandemics: ensuring equity for people affected by COVID-19 and tuberculosis.

Carter J, Friedland J, Kirwan D, Nathavitharana R ERJ Open Res. 2020; 6(4).

PMID: 33204676 PMC: 7659031. DOI: 10.1183/23120541.00562-2020.

COVID-19 and Tuberculosis Coinfection in a 51-Year-Old Taxi Driver in Mexico City.

Martinez Orozco J, Sanchez Tinajero A, Vargas E, Delgado Cueva A, Resendiz Escobar H, Vazquez Alcocer E Am J Case Rep. 2020; 21:e927628.

PMID: 33151912 PMC: 7649741. DOI: 10.12659/AJCR.927628.

References

Tadolini M, Codecasa L, Garcia-Garcia J, Blanc F, Borisov S, Alffenaar J . Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020; 56(1). PMC: 7251245. DOI: 10.1183/13993003.01398-2020. View

Ndjeka N, Schnippel K, Master I, Meintjes G, Maartens G, Romero R . High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen. Eur Respir J. 2018; 52(6). DOI: 10.1183/13993003.01528-2018. View

Sinanovic E, Ramma L, Vassall A, Azevedo V, Wilkinson L, Ndjeka N . Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa. Int J Tuberc Lung Dis. 2015; 19(2):172-8. PMC: 4447891. DOI: 10.5588/ijtld.14.0421. View

Schnippel K, Ndjeka N, Maartens G, Meintjes G, Master I, Ismail N . Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study. Lancet Respir Med. 2018; 6(9):699-706. DOI: 10.1016/S2213-2600(18)30235-2. View

Borisov S, Danila E, Maryandyshev A, Dalcolmo M, Miliauskas S, Kuksa L . Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report. Eur Respir J. 2019; 54(6). DOI: 10.1183/13993003.01522-2019. View